Ken Griffin Soma Logic, Inc. Transaction History

Citadel Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.76 - $2.83 $89,404 - $143,758	50,798 New	50,798 $128,000
Q2 2023 Aug 14, 2023	SELL	$2.1 - $3.36 $120,876 - $193,401	-57,560 Reduced 45.6%	68,673 $158,000
Q1 2023 May 15, 2023	BUY	$2.13 - $3.6 $73,512 - $124,246	34,513 Added 37.63%	126,233 $321,000
Q4 2022 Feb 14, 2023	BUY	$2.05 - $3.47 $150,445 - $254,656	73,388 Added 400.33%	91,720 $230,000
Q3 2022 Nov 14, 2022	SELL	$0.63 - $5.47 $647,986 - $5.63 Million	-1,028,550 Reduced 98.25%	18,332 $53,000

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.